Across TCGA pan-cancer cohorts, ATP8A1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ATP8A1’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where ATP8A1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ATP8A1 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.
COAD, CCRCC, and LUAD are the cancer types where ATP8A1 tumor–normal differential expression is most reproducible.